WHY PHYSICIANS DO NOT FOLLOW AACE/ACE GUIDELINES IN TREATING QUALIFIED PATIENTS WITH T2DM- A SURVEY STUDY IN THE UNITED STATES

Author(s)

Qiu Y1, Li Q1, Tang J2, Fan CS2, Li Z2, Apecechea de Scheffer M3, Hegar R3, Shankar R1, Engel SS1
1Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA, 2AscelpiusAnalytics Ltd., Hong Kong, Hong Kong, 3Kantar Health Germany, Munich, Germany

OBJECTIVES: To assess factors affecting physicians’ decision on why they did not initiate dual therapy to untreated Type 2 Diabetes Mellitus (T2DM) patients with A1C 7.6–9% per AACE/ACE recommendation.

METHODS: Primary care physicians (PCPs) and specialists in the US were asked to provide medical chart reviews for 4 patients who were diagnosed with A1C 7.6-9% and initiated with metformin monotherapy. Physicians rated 22 reasons on a 5-point Likert scale (1-most irrelevant; 5-most relevant) on how relevant each reason was for them in treating a specific patient. Top 5 reasons ( ≥50% of physicians rating the reason as 4 or 5) were identified. Association of each reason on physician specialty or age was conducted using mixed-effect model controlling for physician and patient characteristics.

RESULTS:

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PDB147

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Prescribing Behavior

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×